Primary prevention remains the ultimate challenge and noblest goal for averting the debilitating consequences of chronic disease. In glaucoma, lowering of intraocular pressure remains the only known modifiable risk factor to prevent disease development. The identification of new avenues for intervention, prior to the establishment of disease, is of utmost importance given the anticipated rise in glaucoma prevalence worldwide, especially among high-risk populations.1
Liu Y, Klein BE. The Role of Statins and Cholesterol in the Primary Prevention of Primary Open-Angle Glaucoma. JAMA Ophthalmol. 2019;137(7):765–766. doi:10.1001/jamaophthalmol.2019.0860
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: